生意行为 发表于 2025-3-26 23:39:36

http://reply.papertrans.cn/47/4689/468872/468872_31.png

COM 发表于 2025-3-27 03:02:46

http://reply.papertrans.cn/47/4689/468872/468872_32.png

ORBIT 发表于 2025-3-27 05:19:45

Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development

对待 发表于 2025-3-27 10:03:55

Avraham Yacobi (Director),Jerome P. Skelly (Deputy

使长胖 发表于 2025-3-27 13:54:49

http://reply.papertrans.cn/47/4689/468872/468872_35.png

Consequence 发表于 2025-3-27 20:29:23

http://reply.papertrans.cn/47/4689/468872/468872_36.png

北京人起源 发表于 2025-3-28 01:50:12

http://reply.papertrans.cn/47/4689/468872/468872_37.png

Engaging 发表于 2025-3-28 03:15:35

Use of Pharmacokinetics and Pharmacodynamics in Preclinical Studies to Guide Dosage Escalation Schem–24 months. Overall, there is now a substantial collection of data which demonstrates that coordination with preclinical pharmacology and toxicology studies can save both time and resources in early clinical trials without a loss of safety.

Afflict 发表于 2025-3-28 06:35:19

Use of Toxicokinetic Principles in Drug Development: Bridging Preclinical and Clinical Studiesationship between safe dosages, pharmacologic-toxicologic activities, and blood levels can guide in selecting early dosages for initial administration to man and in subsequent dosing escalation strategy.

门闩 发表于 2025-3-28 13:06:31

Preclinical Pharmacodynamics of Anxiolytics: Effects of Chronic Benzodiazepine Administrationbserved during chronic administration, suggesting the presence of a “withdrawal” syndrome. Administration of carbamazepine after lorazepam discontinuation attenuated the behavioral and neurochemical withdrawal effects. Studies to determine the cellular mechanisms of these receptor alterations indica
页: 1 2 3 [4] 5 6 7
查看完整版本: Titlebook: Integration of Pharmacokinetics, Pharmacodynamics, and Toxicokinetics in Rational Drug Development; Avraham Yacobi (Director),Jerome P. Sk